Sophia Lampaki

Reader in Pulmonology

Aristotle University of Thessaloniki

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sophia Lampaki is a Reader in Pulmonology at Aristotle University of Thessaloniki, Greece. Her research focuses on lung cancer, with recent publications addressing topics such as cost-effective lung cancer screening, treatment patterns in non-small cell lung cancer, and the implications of biomarkers for therapeutic strategies. Additionally, she investigates real-world data related to EGFR mutations and responses to COVID-19 vaccination in cancer patients.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Marios E. Froudarakis

FRANCE

View details

Eleftherios Zervas

Head of 7th Pulmonary Dept.

Sapporo City General Hospital

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sophia Lampaki

Research Interests

Contact this professor

About

Articles (10)

Lung cancer screening with volume computed tomography is cost-effective in Greece

Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study.

Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival prediction.

Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.

Clinical Outcomes Beyond 1L <i>EGFR</i>-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.

Real-world management patterns in <i>EGFR</i>-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.

Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group.

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.

Collaborators (2)

Marios E. Froudarakis

Eleftherios Zervas

Make your next move.